Fig 1. Type 1 diabetes mellitus model was established by intraperitoneal injection of STZ into M-NSG mice.
The results showed that after STZ induction, the model group exhibited elevated blood glucose levels and decreased body weight.
Fig 2. Efficacy evaluation of the type 1 diabetes mellitus model in M-NSG mice.
Fig 1. Type 1 diabetes mellitus model was established in M-SRG rats via intraperitoneal STZ injection.
After STZ induction, the model group exhibited hyperglycemia and reduced body weight.
Fig 2. Efficacy evaluation of the type 1 diabetes mellitus model in M-SRG rats.
The results showed significant improvements in both blood glucose levels and body weight in the treatment group.
Fig.1 Caerulein induced chronic pancreatitis model. (A) Body Weight. (B) Body Weight Chang(%).
Fig.2 Caerulein induced chronic pancreatitis model. (A) photos of pancreas. (B) Relative pancreas weight (mg/g).
The size and weight of pancreas were significantly decreased in caerulein treated mice.
Fig.3 Caerulein induced chronic pancreatitis model.
Obvious atrophy of acinar cells can be observed in caerulein treated mice.
Significant fibrosis was observed in the pancreatic tissue of caerulein treated mice.
